Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Shelley Wood

November 01, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

News Conference News HFSA 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

Todd Neale

September 13, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News Daily News

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

Shelley Wood

August 04, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

Shelley Wood

March 17, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

Shelley Wood

January 07, 2021

Advertisement

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

November 2021 News Roundup

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

July/August 2021 News Roundup

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Roughly 80% of ESC Guideline Writers Have Financial COIs

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content